Pilot Trial Evaluating Viral Protein Production From the Combination of Reolysin and Carfilzomib in Multiple Myeloma
Phase of Trial: Phase I
Latest Information Update: 20 Nov 2019
Price : $35 *
At a glance
- Drugs Carfilzomib (Primary) ; Dexamethasone (Primary) ; Pelareorep (Primary)
- Indications Multiple myeloma
- Focus Adverse reactions; Biomarker
- 22 Aug 2019 Status changed from recruiting to suspended.
- 01 Mar 2019 Planned primary completion date changed from 1 Dec 2018 to 30 Jun 2020.
- 01 Mar 2019 Status changed from suspended to recruiting.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History